)
)
)
Unlocking Precision Diagnosis and Targeted Treatment in PCOS and Uterine Conditions
Gain insight from leaders across diagnostics, therapeutics, and data on how advances in hormonal, metabolic, and genetic biomarkers are enabling earlier and more precise diagnosis of PCOS. Explore how emerging approaches, including AI-driven phenotyping, are shaping the next phase of development and what this means for improving outcomes and unlocking new commercial value across one of the largest and most commercially underdeveloped markets in women's health.
Speakers
